MedTrace Logo

Impact of Biliopancreatic Limb Length on Diabetes Following Distal Gastrectomy

NCT04889859 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-03-14

No results posted yet for this study

Summary

This is a prospective, randomized controlled trial to investigate the impact of a long biliopancreatic limb of Roux-en-Y reconstruction on diabetes control in patients with concurrent type 2 diabetes and gastric cancer

Conditions

  • Stomach Neoplasm
  • Diabetes Mellitus, Type 2

Interventions

PROCEDURE

long Roux limb Roux-en-Y reconstruction

After standard laparoscopic distal gastrectomy with radical lymphadenectomy, the gastrointestinal continuity will be restored with Roux-en-Y reconstruction using 100 cm-long Roux limb and 50 cm-long biliopancreatic limb.

PROCEDURE

long biliopancreatic limb Roux-en-Y reconstruction

After standard laparoscopic distal gastrectomy with radical lymphadenectomy, the gastrointestinal continuity will be restored with Roux-en-Y reconstruction using 50 cm-long Roux limb and 100 cm-long biliopancreatic limb.

Sponsors & Collaborators

  • Kyungpook National University Chilgok Hospital

    lead OTHER

Principal Investigators

  • Ji Yeon Park, MD · Kyungpook National University Chilgok Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2023-02-28
Completion
2023-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04889859 on ClinicalTrials.gov